The effects of adjunctive intranasal oxytocin in patients with schizophrenia

References

• Young WS 3rd, Gainer H. Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors. Neuroendocrinology. 2003;78:185–203.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Macbeth AH, Pagani JH, et al. Oxytocin: the great facilitator of life. Prog Neurobiol. 2009;88:127–151.
   PubMed Web of Science ®Google Scholar
• MacDonald K, MacDonald TM. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry. 2010;18:1–21.
   PubMed Web of Science ®Google Scholar
• Yamasue H, Domes G. Oxytocin and autism spectrum disorders. Curr Top Behav Neurosci. forthcoming.
   Google Scholar
• Lee SY, Lee AR, Hwangbo R, et al. Is oxytocin application for autism spectrum disorder evidence-based? Exp Neurobiolm. 2015;24:312–324.
   PubMed Web of Science ®Google Scholar
• Edwards J, Jackson HJ, Pattison PE. Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clin Psychol Rev. 2002;22:789–832.
   PubMed Web of Science ®Google Scholar
• Tremeau F. A review of emotion deficits in schizophrenia. Dialog Clin Neurosci. 2006;8:59–70.
   PubMedGoogle Scholar
• Bujanow W. Hormones in the treatment of psychoses. Br Med J. 1972;4:298.
   PubMedGoogle Scholar
• Beckmann H, Lang RE, Gattaz WF. Vasopressin–oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology. 1985;10:187–191.
   PubMed Web of Science ®Google Scholar
• Keri S, Kiss I, Kelemen O. Sharing secrets: oxytocin and trust in schizophrenia. Soc Neurosci. 2009;4:287–293.
   PubMed Web of Science ®Google Scholar
• Rubin LH, Carter CS, Drogos L, et al. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr Res. 2010;124:13–21.
   PubMed Web of Science ®Google Scholar
• Sasayama D, Hattori K, Teraishi T, et al. Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia. Schizophr Res. 2012;139:201–206.
   PubMed Web of Science ®Google Scholar
• Montag C, Brockmann EM, Lehmann A, et al. Association between oxytocin receptor gene polymorphisms and self-rated ‘empathic concern’ in schizophrenia. PLoS One. 2012;7:e51882.
   PubMed Web of Science ®Google Scholar
• Montag C, Brockmann EM, Bayerl M, et al. Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: a case-control study. World J Biol Psychiatry. 2013;14:500–508.
   PubMed Web of Science ®Google Scholar
• Haram M, Tesli M, Bettella F, et al. Association between genetic variation in the oxytocin receptor gene and emotional withdrawal, but not between oxytocin pathway genes and diagnosis in psychotic disorders. Front Hum Neurosci. 2015;9:9.
   PubMed Web of Science ®Google Scholar
• Feifel D, Macdonald K, Nguyen A, et al. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry. 2010;68:678–680.
   PubMed Web of Science ®Google Scholar
• Lee MR, Wehring HJ, McMahon RP, et al. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study. Schizophr Res. 2013;145:110–115.
   PubMed Web of Science ®Google Scholar
• Modabbernia A, Rezaei F, Salehi B, et al. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study. CNS Drugs. 2013;27:57–65.
   PubMed Web of Science ®Google Scholar
• Pedersen CA, Gibson CM, Rau SW, et al. Intranasal oxytocin reduces psychotic symptoms and improves theory of mind and social perception in schizophrenia. Schizophr Res. 2011;132:50–53.
   PubMed Web of Science ®Google Scholar
• Cacciotti-Saija C, Langdon R, Ward PB, et al. A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis. Schizophr Bull. 2015;41:483–493.
   PubMed Web of Science ®Google Scholar
• Dagani J, Sisti D, Abelli M, et al. Do we need oxytocin to treat schizophrenia? A randomized clinical trial. Schizophr Res. 2016;172:158–164.
   PubMed Web of Science ®Google Scholar
• Lee MR, Wehring HJ, McMahon RP, et al. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia. Schizophr Res. 2016;172:165–168.
   PubMed Web of Science ®Google Scholar
• Maejima Y, Rita RS, Santoso P, et al. Nasal oxytocin administration reduces food intake without affecting locomotor activity and glycemia with c-Fos induction in limited brain areas. Neuroendocrinology. 2015;101:35–44.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu C, Chen Q, et al. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One. 2013;8:1–11.
   Web of Science ®Google Scholar
• Leng G, Ludwig M. Intranasal oxytocin: myths and delusions. Biol Psychiatry. 2016;79:243–250.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Maejima Y, Suyama S, et al. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity. Am J Physiol Regul Integr Comp Physiol. 2015;308:R360–R369.
   PubMed Web of Science ®Google Scholar
• Manu P, Dima L, Shulman M, et al. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr Scand. 2015;132:97–108.
   PubMed Web of Science ®Google Scholar
• Wigton R, Radua J, Allen P, et al. Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies. J Psychiatry Neurosci. 2015;40:E1–E22.
   PubMed Web of Science ®Google Scholar
• Bartz JA, Zaki J, Bolger N, et al. Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci. 2011;15:30301–30309.
   Web of Science ®Google Scholar
• Koutsouleris N, Gaser C, Jäger M, et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage. 2008;39:1600–1612.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.
   Google Scholar
• Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1–100.
   PubMedGoogle Scholar
• Van Ijzendoorn MH, Bhandari R, Van Der Veen R, et al. Elevated salivary levels of oxytocin persist more than 7 h after intranasal administration. Front Neurosci. 2012;6:174.
   PubMed Web of Science ®Google Scholar
• Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) manual. Schizophr Bull. 1987;13:261–276.
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Sumiyoshi T, Keefe R, et al. Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci. 2007;61:602–609.
   PubMed Web of Science ®Google Scholar
• Baron-Cohen S, Wheelwright S, Hill J, et al. The ‘Reading the Mind in the Eyes’ test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry. 2001a;42:241–251.
   PubMed Web of Science ®Google Scholar
• Baron-Cohen S, Wheelwright S, Skinner R, et al. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001b;31:5–17.
   PubMed Web of Science ®Google Scholar
• Takei R, Matsuo J, Takahashi H, et al. Verification of the utility of the social responsiveness scale for adults in non-clinical and clinical adult populations in Japan. BMC Psychiatry. 2014;14:302.
   PubMed Web of Science ®Google Scholar
• Parker G, Rosen A, Emdur N, et al. The life skills profile: psychometric properties of a measure assessing function and disability in schizophrenia. Acta Psychiatr Scand. 1991;83:145–152.
   PubMed Web of Science ®Google Scholar
• Domes G, Lischke A, Berger C, et al. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology. 2010;35:83–93.
   PubMed Web of Science ®Google Scholar
• Riem MM, Bakermans-Kranenburg MJ, Pieper S, et al. Oxytocin modulates amygdala, insula, and inferior frontal gyrus responses to infant crying: a randomized controlled trial. Biol Psychiatry. 2011;70:291–297.
   PubMed Web of Science ®Google Scholar
• Striepens N, Scheele D, Kendrick KM, et al. Oxytocin facilitates protective responses to aversive social stimuli in males. Proc Natl Acad Sci USA. 2012;109:18144–18149.
   PubMed Web of Science ®Google Scholar
• Striepens N, Km K, Hanking V, et al. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep. 2013;3:3440.
   PubMed Web of Science ®Google Scholar
• Denny BT, Fan J, Liu X, et al. Insula-amygdala functional connectivity is correlated with habituation to repeated negative images. Soc Cogn Affect Neurosci. 2014;9:1660–1667.
   PubMed Web of Science ®Google Scholar
• Pinkham A, Loughead J, Ruparel K, et al. Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI. Psychiatry Res. 2011;194:64–72.
   PubMed Web of Science ®Google Scholar
• Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72:41–51.
   PubMed Web of Science ®Google Scholar
• Bokat CE, Goldberg TE. Letter and category fluency in schizophrenic patients: a meta-analysis. Schizophr Res. 2003;64:73–78.
   PubMed Web of Science ®Google Scholar
• Nicodemus KK, Elvevåg B, Foltz PW, et al. Category fluency, latent semantic analysis and schizophrenia: a candidate gene approach. Cortex. 2014;55:182–191.
   PubMed Web of Science ®Google Scholar
• Basho S, Palmer ED, Rubio MA, et al. Effects of generation mode in fMRI adaptations of semantic fluency: paced production and overt speech. Neuropsychologia. 2007;45:1697–1706.
   PubMed Web of Science ®Google Scholar
• Costafreda SG, David AS, Brammer MJ. A parametric approach to voxelbased meta-analysis. Neuroimage. 2009;46:115–122.
   PubMed Web of Science ®Google Scholar
• Tanji J, Hoshi E. Role of the lateral prefrontal cortex in executive behavioral control. Physiol Rev. 2008;88:37–57.
   PubMed Web of Science ®Google Scholar
• Carter CS, Van Veen V. Anterior cingulate cortex and conflict detection: an update of theory and data. Cogn Affect Behav Neurosci. 2007;7:367–379.
   PubMed Web of Science ®Google Scholar
• Boccia ML, Petrusz P, Suzuki K, et al. Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience. 2013;253:155–164.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Abe O, Kuwabara H, et al. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial. JAMA Psychiatry. 2014;71:166–175.
   PubMed Web of Science ®Google Scholar
• De Berardis D, Marini S, Iasevoli F, et al. The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review. CNS Neurol Disord Drug Targets. 2013;12:252–264.
   PubMed Web of Science ®Google Scholar
• Shamay-Tsoory SG, Fischer M, Dvash J, et al. Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biol Psychiatry. 2009;66:864–870.
   PubMed Web of Science ®Google Scholar
• Grillon C, Krimsky M, Charney DR, et al. Oxytocin increases anxiety to unpredictable threat. Mol Psychiatry. 2013;18:958–960.
   PubMed Web of Science ®Google Scholar
• Thienel M, Fritsche A, Heinrichs M, et al. Oxytocin’s inhibitory effect on food intake is stronger in obese than normal-weight men. Int J Obes (Lond). 2016;40:1707–1714.
   PubMed Web of Science ®Google Scholar
• Yanovski JA, Yanovski SZ, Sovik KN, et al. A prospective study of holiday weight gain. N Engl J Med. 2000;342:861–867.
   PubMed Web of Science ®Google Scholar